Browse > Article
http://dx.doi.org/10.14476/jomp.2019.44.1.1

Evaluation of Clinically Effective Doses of Triamcinolone Acetonide for Intralesional Injection in Oral Lichen Planus  

Park, Su-Hyeon (Department of Oral Medicine, Dental Research Institute, Institute of Translational Dental Sciences, School of Dentistry, Pusan National University)
Lee, Hae-Ohk (Department of Oral Medicine, Dental Research Institute, Institute of Translational Dental Sciences, School of Dentistry, Pusan National University)
Ju, Hye-Min (Department of Oral Medicine, Dental Research Institute, Institute of Translational Dental Sciences, School of Dentistry, Pusan National University)
Lee, Ji-Yeon (Department of Oral Medicine, Dental Research Institute, Institute of Translational Dental Sciences, School of Dentistry, Pusan National University)
Jeon, Hye-Mi (Department of Oral Medicine, Pusan National University Hospital)
Ok, Soo-Min (Department of Oral Medicine, Dental Research Institute, Institute of Translational Dental Sciences, School of Dentistry, Pusan National University)
Ahn, Yong-Woo (Department of Oral Medicine, Dental Research Institute, Institute of Translational Dental Sciences, School of Dentistry, Pusan National University)
Jeong, Sung-Hee (Department of Oral Medicine, Dental Research Institute, Institute of Translational Dental Sciences, School of Dentistry, Pusan National University)
Publication Information
Journal of Oral Medicine and Pain / v.44, no.1, 2019 , pp. 1-10 More about this Journal
Abstract
Purpose: The aim of this study was to evaluate the optimal doses of intralesional triamcinolone acetonide (TA) in the treatment of oral lichen planus (OLP). Methods: A randomized clinical trial was performed. Sixty-two lesions of OLP were received 12 mg (group A) or 20 mg (group B) of TA intralesionally weekly for 2 weeks. Subjective symptoms, lesion size, favorable conversion of clinical subtypes, and clinical response were evaluated at weeks 0, 1, 2, and 4. Results: After two consecutive injections of TA, group B showed significant reduction in burning sensation and reticular area (p<0.01). Favorable conversion and complete response were greater in group B. Mild oral candidiasis was developed in group B (10.7%). Conclusions: A 20-mg injection of TA was much more effective compared with 12-mg injection of TA in the treatment of OLP.
Keywords
Intralesional injections; Oral lichen planus; Triamcinolone acetonide;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Mollaoglu N. Oral lichen planus: a review. Br J Oral Maxillofac Surg 2000;38:370-377.   DOI
2 Scully C, el-Kom M. Lichen planus: review and update on pathogenesis. J Oral Pathol 1985;14:431-458.   DOI
3 Al-Hashimi I, Schifter M, Lockhart PB, et al. Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103 Suppl:S25.e1-e12.
4 Lodi G, Scully C, Carrozzo M, Griffiths M, Sugerman PB, Thongprasom K. Current controversies in oral lichen planus: report of an international consensus meeting. Part 1. Viral infections and etiopathogenesis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;100:40-51.   DOI
5 Lodi G, Carrozzo M, Furness S, Thongprasom K. Interventions for treating oral lichen planus: a systematic review. Br J Dermatol 2012;166:938-947.   DOI
6 Andreasen JO. Oral lichen planus. 1. A clinical evaluation of 115 cases. Oral Surg Oral Med Oral Pathol 1968;25:31-42.   DOI
7 Eisen D, Carrozzo M, Bagan Sebastian JV, Thongprasom K. Number V Oral lichen planus: clinical features and management. Oral Dis 2005;11:338-349.   DOI
8 Dissemond J. Oral lichen planus: an overview. J Dermatolog Treat 2004;15:136-140.   DOI
9 Radfar L, Wild RC, Suresh L. A comparative treatment study of topical tacrolimus and clobetasol in oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;105:187-193.   DOI
10 Carbone M, Goss E, Carrozzo M, et al. Systemic and topical corticosteroid treatment of oral lichen planus: a comparative study with long-term follow-up. J Oral Pathol Med 2003;32:323-329.   DOI
11 Sonthalia S, Singal A. Comparative efficacy of tacrolimus 0.1% ointment and clobetasol propionate 0.05% ointment in oral lichen planus: a randomized double-blind trial. Int J Dermatol 2012;51:1371-1378.   DOI
12 Petruzzi M, Lucchese A, Lajolo C, Campus G, Lauritano D, Serpico R. Topical retinoids in oral lichen planus treatment: an overview. Dermatology 2013;226:61-67.   DOI
13 McCreary CE, McCartan BE. Clinical management of oral lichen planus. Br J Oral Maxillofac Surg 1999;37:338-343.   DOI
14 Agarwal R, Saraswat A. Oral lichen planus: an update. Drugs Today (Barc) 2002;38:533-547.   DOI
15 Kumar S, Singh RJ, Reed AM, Lteif AN. Cushing's syndrome after intra-articular and intradermal administration of triamcinolone acetonide in three pediatric patients. Pediatrics 2004;113:1820-1824.   DOI
16 Jeal W, Faulds D. Triamcinolone acetonide. A review of its pharmacological properties and therapeutic efficacy in the management of allergic rhinitis. Drugs 1997;53:257-280.   DOI
17 Xia J, Li C, Hong Y, Yang L, Huang Y, Cheng B. Short-term clinical evaluation of intralesional triamcinolone acetonide injection for ulcerative oral lichen planus. J Oral Pathol Med 2006;35:327-331.   DOI
18 Kuo RC, Lin HP, Sun A, Wang YP. Prompt healing of erosive oral lichen planus lesion after combined corticosteroid treatment with locally injected triamcinolone acetonide plus oral prednisolone. J Formos Med Assoc 2013;112:216-220.   DOI
19 Lee YC, Shin SY, Kim SW, Eun YG. Intralesional injection versus mouth rinse of triamcinolone acetonide in oral lichen planus: a randomized controlled study. Otolaryngol Head Neck Surg 2013;148:443-449.   DOI
20 Vincent SD. Diagnosing and managing oral lichen planus. J Am Dent Assoc 1991;122:93-94, 96.   DOI
21 Sleeper HR. Intralesional and sublesional injection of triamcinolone acetonide for oral lichen planus. Yale J Biol Med 1967;40:164-165.
22 Setterfield JF, Black MM, Challacombe SJ. The management of oral lichen planus. Clin Exp Dermatol 2000;25:176-182.   DOI
23 Sugerman PB, Savage NW, Zhou X, Walsh LJ, Bigby M. Oral lichen planus. Clin Dermatol 2000;18:533-539.   DOI
24 Yoke PC, Tin GB, Kim MJ, et al. A randomized controlled trial to compare steroid with cyclosporine for the topical treatment of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;102:47-55.   DOI
25 van der Meij EH, van der Waal I. Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications. J Oral Pathol Med 2003;32:507-512.   DOI
26 Khanna JN, Andrade NN. Oral submucous fibrosis: a new concept in surgical management. Report of 100 cases. Int J Oral Maxillofac Surg 1995;24:433-439.   DOI
27 Skedros JG, Hunt KJ, Pitts TC. Variations in corticosteroid/anesthetic injections for painful shoulder conditions: comparisons among orthopaedic surgeons, rheumatologists, and physical medicine and primary-care physicians. BMC Musculoskelet Disord 2007;8:63.   DOI
28 Chang KH, Rojhirunsakool S, Goldberg LJ. Treatment of severe alopecia areata with intralesional steroid injections. J Drugs Dermatol 2009;8:909-912.
29 Weshahy AH, Abdel Hay R. Intralesional cryosurgery and intralesional steroid injection: a good combination therapy for treatment of keloids and hypertrophic scars. Dermatol Ther 2012;25:273-276.   DOI
30 Prasetyono TO, Djoenaedi I. Efficacy of intralesional steroid injection in head and neck hemangioma: a systematic review. Ann Plast Surg 2011;66:98-106.   DOI
31 Osterne RL, Araujo PM, de Souza-Carvalho AC, Cavalcante RB, Sant'Ana E, Nongueira RL. Intralesional corticosteroid injections in the treatment of central giant cell lesions of the jaws: a metaanalytic study. Med Oral Patol Oral Cir Bucal 2013;18:e226-e232.
32 Zegarelli DJ. Ulcerative and erosive lichen planus. Treated by modified topical steroid and injection steroid therapy. N Y State Dent J 1987;53:23-24.
33 Hegarty AM, Hodgson TA, Lewsey JD, Porter SR. Fluticasone propionate spray and betamethasone sodium phosphate mouthrinse: a randomized crossover study for the treatment of symptomatic oral lichen planus. J Am Acad Dermatol 2002;47:271-279.   DOI
34 Sankar V, Hearnden V, Hull K, et al. Local drug delivery for oral mucosal diseases: challenges and opportunities. Oral Dis 2011;17 Suppl 1:73-84.   DOI
35 Kaliakatsou F, Hodgson TA, Lewsey JD, Hegarty AM, Murphy AG, Porter SR. Management of recalcitrant ulcerative oral lichen planus with topical tacrolimus. J Am Acad Dermatol 2002;46:35-41.   DOI
36 Fu J, Zhu X, Dan H, et al. Amlexanox is as effective as dexamethasone in topical treatment of erosive oral lichen planus: a short-term pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol 2012;113:638-643.   DOI
37 Sun A, Chia JS, Chang YF, Chiang CP. Serum interleukin-6 level is a useful marker in evaluating therapeutic effects of levamisole and Chinese medicinal herbs on patients with oral lichen planus. J Oral Pathol Med 2002;31:196-203.   DOI
38 Thongprasom K, Luangjarmekorn L, Sererat T, Taweesap W. Relative efficacy of fluocinolone acetonide compared with triamcinolone acetonide in treatment of oral lichen planus. J Oral Pathol Med 1992;21:456-458.   DOI
39 Chen HM, Shih CC, Yen KL, et al. Facial Candida albicans cellulitis occurring in a patient with oral submucous fibrosis and unknown diabetes mellitus after local corticosteroid injection treatment. J Oral Pathol Med 2004;33:243-245.   DOI
40 Malhotra AK, Khaitan BK, Sethuraman G, Sharma VK. Betamethasone oral mini-pulse therapy compared with topical triamcinolone acetonide (0.1%) paste in oral lichen planus: a randomized comparative study. J Am Acad Dermatol 2008;58:596-602.   DOI
41 Gonzalez-Garcia A, Diniz-Freitas M, Gandara-Vila P, Blanco-Carrion A, Garcia-Garcia A, Gandara-Rey J. Triamcinolone acetonide mouth rinses for treatment of erosive oral lichen planus: efficacy and risk of fungal over-infection. Oral Dis 2006;12:559-565.   DOI
42 Buajeeb W, Pobrurksa C, Kraivaphan P. Efficacy of fluocinolone acetonide gel in the treatment of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;89:42-45.   DOI
43 Camisa C, Rindler JM. Diseases of the oral mucous membranes. Curr Probl Dermatol 1996;8:43-96.   DOI
44 Scully C, Beyli M, Ferreiro MC, et al. Update on oral lichen planus: etiopathogenesis and management. Crit Rev Oral Biol Med 1998;9:86-122.   DOI
45 Xiong C, Li Q, Lin M, et al. The efficacy of topical intralesional BCG-PSN injection in the treatment of erosive oral lichen planus: a randomized controlled trial. J Oral Pathol Med 2009;38:551-558.   DOI
46 Dusek JJ, Frick WG. Lichen planus: oral manifestations and suggested treatments. J Oral Maxillofac Surg 1982;40:240-244.   DOI